Indication
Fosrego® (Sevelamer Carbonate 400 mg / 800 mg) is a phosphate binder indicated in hyperphosphatemia to control serum phosphorus levels in chronic kidney disease patients, including those on dialysis.
Mechanism of action
Fosrego® is a non-metal, non-absorbing phosphate binder. The polymer binds phosphate throughout the gut, reducing systemic absorption of dietary phosphorus and lowering serum phosphate without contributing to calcium load.
Strengths
- •400 mg tablet
- •800 mg tablet
Composition
Fosrego®-400 - each tablet contains Sevelamer Carbonate 400 mg. Fosrego®-800 - each tablet contains Sevelamer Carbonate 800 mg.
Presentation
Alu-alu pack of 10 tablets in one strip, 10 strips in a box (both strengths).
For Healthcare Professionals
Dosing guided by serum phosphorus: >7.5 mg/dL → two tablets of Fosrego®-800 three times daily with meals; 5.5–7.5 mg/dL → one tablet of Fosrego®-800 three times daily with meals; 4.5–5.5 mg/dL → one tablet of Fosrego®-400 three times daily with meals.
This section is intended for use by registered medical practitioners only. All clinical decisions remain the prescriber's responsibility and should be informed by the current approved product label.
Notes for patients & caregivers
Take with each meal exactly as your nephrologist prescribes. Swallow whole; do not crush.
These notes are for general awareness only and are not a substitute for medical advice. Please follow your treating physician's instructions and the directions on the dispensed product.
Storage
Store below 25°C. Keep tightly closed.
Important
- • Fosrego® is a prescription medicine. It must only be used on the advice of a registered medical practitioner.
- • Always refer to the current approved Indian product label / package insert for definitive prescribing information.
- • If you experience any quality or safety concern, please contact us or write to info@vyapitus.com.